Literature DB >> 29424961

Global trends in mortality from malignant mesothelioma: Analysis of WHO mortality database (1994-2013).

Omar Abdel-Rahman1.   

Abstract

BACKGROUND AND
OBJECTIVE: Little is known about the extent to which asbestos use ban has affected global trends in malignant mesothelioma. This study investigated recent global mortality trends of malignant mesothelioma.
METHODS: Data were collected from International Agency for Research on Cancer/World Health Organization mortality database to examine age-standardized, gender-specific mortality rates for malignant mesothelioma (ICD10-C45). Cross-sectional mortality rates (2009-2013) as well as trends over time (1994-2013) were also reported. Gender-specific annual percent change (APC) was calculated to examine trends over time for each country.
RESULTS: Among the 30 countries with highest mesothelioma mortality in men, there is almost 10-fold variation in mortality rates during 2009-2013 ranging from 6.25 per 100 000 for United Kingdom to 0.64 per 100 000 in Portugal; whereas, among the 30 countries with highest mesothelioma mortality in women, there is a 4-fold variation in mortality rates during 2009-2013 ranging from 1.08 per 100 000 for United Kingdom to 0.26 per 100 000 in Ireland. Mortality rates were higher in men compared to women in 32 out of 35 evaluable countries. Among males and over the last 10 years of covered years, mesothelioma mortality was significantly declining in 9 countries (United Kingdom, Sweden, France, Germany, Netherlands, Canada, United States, Australia, and New Zealand); whereas, it was significantly rising in 5 countries (Poland, Spain, China-Hong Kong, Japan, and Republic of Korea). In the remaining countries, APC was stable. Among females and over the last 10 years of covered years, mesothelioma mortality was significantly declining in 1 country only (Italy); whereas, it was significantly rising in 3 countries (Poland, Argentina, and Republic of Korea). In the remaining countries, APC was stable.
CONCLUSIONS: There is a worldwide variability in the burden and trends of mesothelioma mortality; and despite the ban on asbestos in many countries, mesothelioma still represents an important cause of mortality.
© 2018 John Wiley & Sons Ltd.

Entities:  

Keywords:  cancer registries; malignant mesothelioma; mortality; surveillance

Mesh:

Year:  2018        PMID: 29424961     DOI: 10.1111/crj.12778

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  8 in total

1.  Pleural mesothelioma risk by industry and occupation: results from the Multicentre Italian Study on the Etiology of Mesothelioma (MISEM).

Authors:  Enrica Migliore; Dario Consonni; Susan Peters; Roel C H Vermeulen; Hans Kromhout; Antonio Baldassarre; Domenica Cavone; Elisabetta Chellini; Corrado Magnani; Carolina Mensi; Enzo Merler; Marina Musti; Alessandro Marinaccio; Dario Mirabelli
Journal:  Environ Health       Date:  2022-06-18       Impact factor: 7.123

2.  Asbestos bodies count and morphometry in bulk lung tissue samples by non-invasive X-ray micro-tomography.

Authors:  Fabrizio Bardelli; Francesco Brun; Silvana Capella; Donata Bellis; Claudia Cippitelli; Alessia Cedola; Elena Belluso
Journal:  Sci Rep       Date:  2021-05-19       Impact factor: 4.379

3.  BCL-XL is an actionable target for treatment of malignant pleural mesothelioma.

Authors:  Surein Arulananda; Megan O'Brien; Marco Evangelista; Tiffany J Harris; Nikita S Steinohrt; Laura J Jenkins; Marzena Walkiewicz; Robert J J O'Donoghue; Ashleigh R Poh; Bibhusal Thapa; David S Williams; Trishe Leong; John M Mariadason; Xia Li; Jonathan Cebon; Erinna F Lee; Thomas John; W D Fairlie
Journal:  Cell Death Discov       Date:  2020-10-31

4.  Overexpression of fibulin-3 in tumor tissue predicts poor survival of malignant mesothelioma patients from hand-spinning asbestos exposed area in eastern China.

Authors:  Zhaoqiang Jiang; Wei Shen; Shibo Ying; Zhibin Gao; Xianglei He; Riping Chen; Hailing Xia; Xinnian Guo; Yuan Fang; Yixiao Zhang; Jianjiang Miao; Jian Zhou; Xing Zhang; Junqiang Chen; Jianlin Lou
Journal:  Sci Rep       Date:  2020-11-23       Impact factor: 4.379

5.  Metastasis-associated gene 1 (MTA1) enhances cisplatin resistance of malignant pleural mesothelioma by ATR-Chk1-mediated DNA repair.

Authors:  Caihua Xu; Yufeng Hu; Bin Chen; Dapeng Li; Rongrui Liang; Meng Shen; Mengyao Wu; Min Tao
Journal:  Ann Transl Med       Date:  2021-04

Review 6.  Salvage Therapy for Relapsed Malignant Pleural Mesothelioma: A Systematic Review and Network Meta-Analysis.

Authors:  Yu-Chen Tsai; Hsiao-Ling Chen; Tai-Huang Lee; Hsiu-Mei Chang; Kuan-Li Wu; Cheng-Hao Chuang; Yong-Chieh Chang; Yu-Kang Tu; Jen-Yu Hung; Chih-Jen Yang; Inn-Wen Chong
Journal:  Cancers (Basel)       Date:  2021-12-30       Impact factor: 6.639

7.  Mortality due to respiratory system disease and lung cancer among female workers exposed to chrysotile in Eastern China: A cross-sectional study.

Authors:  Zhaoqiang Jiang; Junqiang Chen; Junfei Chen; Lingfang Feng; Mingying Jin; Huixian Zhong; Li Ju; Lijin Zhu; Yun Xiao; Zhenyu Jia; Chengmin Xu; Difang Yu; Xing Zhang; Jianlin Lou
Journal:  Front Oncol       Date:  2022-08-01       Impact factor: 5.738

Review 8.  A narrative review of the health disparities associated with malignant pleural mesothelioma.

Authors:  Devon C Freudenberger; Rachit D Shah
Journal:  J Thorac Dis       Date:  2021-06       Impact factor: 2.895

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.